Skip to main content
OpenTrials
Completed

NCT Number: NCT01532219

Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with major depression and/or anxiety disorders and compare its efficacy to an active control group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linköping University, Department of Behavioral Sciences and Learning

Linköping, 58183, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, Generalized Anxiety disorder, Depressive Disorder NOS or Anxiety Disorder NOS
  • 10 or higher on the PHQ-9 or on the GAD-7 at pre-treatment

Exclusion criteria

  • Primary diagnosis of Obsessive Compulsive Disorder or Post-traumatic Stress Disorder
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Alcohol abuse (more than 16 on the AUDIT)
  • Suicidal (measured in diagnostic interview)
  • Changed medication during the last three months

Treatment and study plan

Internet-delivered Psychodynamic Treatment

Behavioral

Ten weeks of guided self-help + therapist contact, via the Internet.

Internet-delivered structured support

Behavioral

Ten weeks of therapist contact, via the Internet.

Primary outcomes

  1. 9-item Patient Health Questionnaire Depression Scale (PHQ-9)

    Time frame: Two weeks before the treatment starts

  2. 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: Two weeks before the treatment starts

  3. 9-item Patient Health Questionnaire Depression Scale (PHQ-9)

    Time frame: At treatment start (0 weeks)

  4. 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: At treatment start (0 weeks)

  5. 9-item Patient Health Questionnaire Depression Scale (PHQ-9)

    Time frame: At treatment termination (10 weeks)

  6. 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: At treatment termination (10 weeks)

  7. 9-item Patient Health Questionnaire Depression Scale (PHQ-9)

    Time frame: At treatment follow-up (7 months)

  8. 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: At treatment follow-up (7 months)

Secondary outcomes

  1. Emotional Processing Scale (EPS-25)

    Time frame: Two weeks before the treatment starts

  2. Emotional Processing Scale (EPS-25)

    Time frame: At treatment start (0 weeks)

  3. Emotional Processing Scale (EPS-25)

    Time frame: At treatment termination (10 weeks)

  4. Five Facets of Mindfulness Questionnaire (FFMQ)

    Time frame: Two weeks before the treatment starts

  5. Five Facets of Mindfulness Questionnaire (FFMQ)

    Time frame: At treatment start (0 weeks)

  6. Five Facets of Mindfulness Questionnaire (FFMQ)

    Time frame: At treatment termination (10 weeks)

  7. Emotional Processing Scale (EPS-25)

    Time frame: At treatment follow-up (7 months)

  8. Five Facets of Mindfulness Questionnaire (FFMQ)

    Time frame: At treatment follow-up (7 months)

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Registry information

Official study title

Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders: A Randomized Controlled Trial

Acronym: ATLAS

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Feb 14, 2012
Registry last updated
Apr 24, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.